Need for Supply Chain Resiliance & Diversification
Centralized factories create major supply chain risks amid trade wars, tariffs, geopolitical crises, pandemics, and conflicts.
Today, 60% of pharma companies are moving toward nearshoring and local production to reduce these risks [8]. But scaling distributed sites while ensuring quality and controlling costs is tough.
Leumas’ modular, software-driven factories solve this — enabling decentralized, cost-efficient production with consistent quality and remote supervision. [2]
Reshoring / Nearshoring Movement & Localized Production
Trade barriers, geopolitical shifts, rising freight costs, and logistics challenges are driving the move to local and nearshore manufacturing. Governments worldwide are backing this with grants and tax incentives. [9, 10]
Yet, high setup and operating costs remain a hurdle in many regions. Modular, software-led factories offer a solution — enabling low-investment, near-autonomous facilities staffed by local, upskilled workers, making onshore manufacturing both viable and scalable.
Sustainability Imperative
Governments and consumers demand eco-friendly production – pushing brands to reduce carbon footprints, waste, and excessive energy use. Traditional large-scale factories generate significant waste due to overproduction, cold-start problems, inefficient batch processing, downstream fulfillment logistics and cold chain requirements. Distributed, continuous production cuts waste by making products on-demand, using fewer resources, lowering energy use, slashing logistics and storage costs, and supporting local workforces — all while shrinking the carbon footprint. [11]
